The global Bronchiectasis Drugs Market size was valued at US$ 856.7 million in 2024 and is projected to reach US$ 1.23 billion by 2030, at a CAGR of 6.2% during the forecast period 2024-2030.
The United States Bronchiectasis Drugs Market size was valued at US$ 278.4 million in 2024 and is projected to US$ 389.5 million by 2030, at a CAGR of 5.8% during the forecast period 2024-2030.
Pharmaceutical treatments for bronchiectasis management and symptoms.
Patient treatments reached 850,000 in 2023. Inhaled antibiotics grow at 7.8% annually. Market saw 42% increase in combination therapies. Approvals obtained in 45 countries. Future projects worth US$ 345.6 million by 2026. North America leads with 45% market share.
Report Overview
Diagnosis methods of bacterial lung infections have several limitations, including failure to precisely recognize the cause of infection and inability to provide a full representation of the bacterial load present in the lungs. This has driven researchers to develop a new probe, which can detect bacteria in the lungs efficiently.
This report provides a deep insight into the global Bronchiectasis Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Bronchiectasis Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Bronchiectasis Drugs market in any manner.
Global Bronchiectasis Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Endo International Plc
- GlaxoSmithKline Plc
- Neopharma LLC
- Pfizer Inc.
- Reckitt Benckiser Group Plc
- Including or Excluding key companies relevant to your analysis.
Market Segmentation (by Type)
- Antibiotics
- Expectorants
- Other drugs
Market Segmentation (by Application)
- Hospital
- Research institute
- Clinic
- Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Bronchiectasis Drugs Market
- Overview of the regional outlook of the Bronchiectasis Drugs Market:
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Bronchiectasis Drugs
1.2 Key Market Segments
1.2.1 Bronchiectasis Drugs Segment by Type
1.2.2 Bronchiectasis Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Bronchiectasis Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Bronchiectasis Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Bronchiectasis Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Bronchiectasis Drugs Market Competitive Landscape
3.1 Global Bronchiectasis Drugs Sales by Manufacturers (2019-2024)
3.2 Global Bronchiectasis Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Bronchiectasis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Bronchiectasis Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Bronchiectasis Drugs Sales Sites, Area Served, Product Type
3.6 Bronchiectasis Drugs Market Competitive Situation and Trends
3.6.1 Bronchiectasis Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Bronchiectasis Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Bronchiectasis Drugs Industry Chain Analysis
4.1 Bronchiectasis Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Bronchiectasis Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Bronchiectasis Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Bronchiectasis Drugs Sales Market Share by Type (2019-2024)
6.3 Global Bronchiectasis Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Bronchiectasis Drugs Price by Type (2019-2024)
7 Bronchiectasis Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Bronchiectasis Drugs Market Sales by Application (2019-2024)
7.3 Global Bronchiectasis Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Bronchiectasis Drugs Sales Growth Rate by Application (2019-2024)
8 Bronchiectasis Drugs Market Segmentation by Region
8.1 Global Bronchiectasis Drugs Sales by Region
8.1.1 Global Bronchiectasis Drugs Sales by Region
8.1.2 Global Bronchiectasis Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Bronchiectasis Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Bronchiectasis Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Bronchiectasis Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Bronchiectasis Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Bronchiectasis Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Endo International Plc
9.1.1 Endo International Plc Bronchiectasis Drugs Basic Information
9.1.2 Endo International Plc Bronchiectasis Drugs Product Overview
9.1.3 Endo International Plc Bronchiectasis Drugs Product Market Performance
9.1.4 Endo International Plc Business Overview
9.1.5 Endo International Plc Bronchiectasis Drugs SWOT Analysis
9.1.6 Endo International Plc Recent Developments
9.2 GlaxoSmithKline Plc
9.2.1 GlaxoSmithKline Plc Bronchiectasis Drugs Basic Information
9.2.2 GlaxoSmithKline Plc Bronchiectasis Drugs Product Overview
9.2.3 GlaxoSmithKline Plc Bronchiectasis Drugs Product Market Performance
9.2.4 GlaxoSmithKline Plc Business Overview
9.2.5 GlaxoSmithKline Plc Bronchiectasis Drugs SWOT Analysis
9.2.6 GlaxoSmithKline Plc Recent Developments
9.3 Neopharma LLC
9.3.1 Neopharma LLC Bronchiectasis Drugs Basic Information
9.3.2 Neopharma LLC Bronchiectasis Drugs Product Overview
9.3.3 Neopharma LLC Bronchiectasis Drugs Product Market Performance
9.3.4 Neopharma LLC Bronchiectasis Drugs SWOT Analysis
9.3.5 Neopharma LLC Business Overview
9.3.6 Neopharma LLC Recent Developments
9.4 Pfizer Inc.
9.4.1 Pfizer Inc. Bronchiectasis Drugs Basic Information
9.4.2 Pfizer Inc. Bronchiectasis Drugs Product Overview
9.4.3 Pfizer Inc. Bronchiectasis Drugs Product Market Performance
9.4.4 Pfizer Inc. Business Overview
9.4.5 Pfizer Inc. Recent Developments
9.5 Reckitt Benckiser Group Plc
9.5.1 Reckitt Benckiser Group Plc Bronchiectasis Drugs Basic Information
9.5.2 Reckitt Benckiser Group Plc Bronchiectasis Drugs Product Overview
9.5.3 Reckitt Benckiser Group Plc Bronchiectasis Drugs Product Market Performance
9.5.4 Reckitt Benckiser Group Plc Business Overview
9.5.5 Reckitt Benckiser Group Plc Recent Developments
10 Bronchiectasis Drugs Market Forecast by Region
10.1 Global Bronchiectasis Drugs Market Size Forecast
10.2 Global Bronchiectasis Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Bronchiectasis Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Bronchiectasis Drugs Market Size Forecast by Region
10.2.4 South America Bronchiectasis Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Bronchiectasis Drugs by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Bronchiectasis Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Bronchiectasis Drugs by Type (2025-2030)
11.1.2 Global Bronchiectasis Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Bronchiectasis Drugs by Type (2025-2030)
11.2 Global Bronchiectasis Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Bronchiectasis Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Bronchiectasis Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Bronchiectasis Drugs Market Size Comparison by Region (M USD)
Table 5. Global Bronchiectasis Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Bronchiectasis Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Bronchiectasis Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Bronchiectasis Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bronchiectasis Drugs as of 2022)
Table 10. Global Market Bronchiectasis Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Bronchiectasis Drugs Sales Sites and Area Served
Table 12. Manufacturers Bronchiectasis Drugs Product Type
Table 13. Global Bronchiectasis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Bronchiectasis Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Bronchiectasis Drugs Market Challenges
Table 22. Global Bronchiectasis Drugs Sales by Type (Kilotons)
Table 23. Global Bronchiectasis Drugs Market Size by Type (M USD)
Table 24. Global Bronchiectasis Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Bronchiectasis Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Bronchiectasis Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Bronchiectasis Drugs Market Size Share by Type (2019-2024)
Table 28. Global Bronchiectasis Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Bronchiectasis Drugs Sales (Kilotons) by Application
Table 30. Global Bronchiectasis Drugs Market Size by Application
Table 31. Global Bronchiectasis Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Bronchiectasis Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Bronchiectasis Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Bronchiectasis Drugs Market Share by Application (2019-2024)
Table 35. Global Bronchiectasis Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Bronchiectasis Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Bronchiectasis Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Bronchiectasis Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Bronchiectasis Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Bronchiectasis Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Bronchiectasis Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Bronchiectasis Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Endo International Plc Bronchiectasis Drugs Basic Information
Table 44. Endo International Plc Bronchiectasis Drugs Product Overview
Table 45. Endo International Plc Bronchiectasis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Endo International Plc Business Overview
Table 47. Endo International Plc Bronchiectasis Drugs SWOT Analysis
Table 48. Endo International Plc Recent Developments
Table 49. GlaxoSmithKline Plc Bronchiectasis Drugs Basic Information
Table 50. GlaxoSmithKline Plc Bronchiectasis Drugs Product Overview
Table 51. GlaxoSmithKline Plc Bronchiectasis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. GlaxoSmithKline Plc Business Overview
Table 53. GlaxoSmithKline Plc Bronchiectasis Drugs SWOT Analysis
Table 54. GlaxoSmithKline Plc Recent Developments
Table 55. Neopharma LLC Bronchiectasis Drugs Basic Information
Table 56. Neopharma LLC Bronchiectasis Drugs Product Overview
Table 57. Neopharma LLC Bronchiectasis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Neopharma LLC Bronchiectasis Drugs SWOT Analysis
Table 59. Neopharma LLC Business Overview
Table 60. Neopharma LLC Recent Developments
Table 61. Pfizer Inc. Bronchiectasis Drugs Basic Information
Table 62. Pfizer Inc. Bronchiectasis Drugs Product Overview
Table 63. Pfizer Inc. Bronchiectasis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Pfizer Inc. Business Overview
Table 65. Pfizer Inc. Recent Developments
Table 66. Reckitt Benckiser Group Plc Bronchiectasis Drugs Basic Information
Table 67. Reckitt Benckiser Group Plc Bronchiectasis Drugs Product Overview
Table 68. Reckitt Benckiser Group Plc Bronchiectasis Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Reckitt Benckiser Group Plc Business Overview
Table 70. Reckitt Benckiser Group Plc Recent Developments
Table 71. Global Bronchiectasis Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 72. Global Bronchiectasis Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 73. North America Bronchiectasis Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 74. North America Bronchiectasis Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 75. Europe Bronchiectasis Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 76. Europe Bronchiectasis Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 77. Asia Pacific Bronchiectasis Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 78. Asia Pacific Bronchiectasis Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 79. South America Bronchiectasis Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 80. South America Bronchiectasis Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 81. Middle East and Africa Bronchiectasis Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 82. Middle East and Africa Bronchiectasis Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 83. Global Bronchiectasis Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 84. Global Bronchiectasis Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 85. Global Bronchiectasis Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 86. Global Bronchiectasis Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 87. Global Bronchiectasis Drugs Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Bronchiectasis Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Bronchiectasis Drugs Market Size (M USD), 2019-2030
Figure 5. Global Bronchiectasis Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Bronchiectasis Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Bronchiectasis Drugs Market Size by Country (M USD)
Figure 11. Bronchiectasis Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Bronchiectasis Drugs Revenue Share by Manufacturers in 2023
Figure 13. Bronchiectasis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Bronchiectasis Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Bronchiectasis Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Bronchiectasis Drugs Market Share by Type
Figure 18. Sales Market Share of Bronchiectasis Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Bronchiectasis Drugs by Type in 2023
Figure 20. Market Size Share of Bronchiectasis Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Bronchiectasis Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Bronchiectasis Drugs Market Share by Application
Figure 24. Global Bronchiectasis Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Bronchiectasis Drugs Sales Market Share by Application in 2023
Figure 26. Global Bronchiectasis Drugs Market Share by Application (2019-2024)
Figure 27. Global Bronchiectasis Drugs Market Share by Application in 2023
Figure 28. Global Bronchiectasis Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Bronchiectasis Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Bronchiectasis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Bronchiectasis Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Bronchiectasis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Bronchiectasis Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Bronchiectasis Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Bronchiectasis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Bronchiectasis Drugs Sales Market Share by Country in 2023
Figure 37. Germany Bronchiectasis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Bronchiectasis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Bronchiectasis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Bronchiectasis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Bronchiectasis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Bronchiectasis Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Bronchiectasis Drugs Sales Market Share by Region in 2023
Figure 44. China Bronchiectasis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Bronchiectasis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Bronchiectasis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Bronchiectasis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Bronchiectasis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Bronchiectasis Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Bronchiectasis Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Bronchiectasis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Bronchiectasis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Bronchiectasis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Bronchiectasis Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Bronchiectasis Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Bronchiectasis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Bronchiectasis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Bronchiectasis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Bronchiectasis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Bronchiectasis Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Bronchiectasis Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Bronchiectasis Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Bronchiectasis Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Bronchiectasis Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Bronchiectasis Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Bronchiectasis Drugs Market Share Forecast by Application (2025-2030)
